KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Buildings (2016 - 2025)

Boston Scientific's Buildings history spans 17 years, with the latest figure at $2.5 billion for Q4 2025.

  • For Q4 2025, Buildings rose 23.03% year-over-year to $2.5 billion; the TTM value through Dec 2025 reached $2.5 billion, up 23.03%, while the annual FY2025 figure was $2.5 billion, 23.03% up from the prior year.
  • Buildings for Q4 2025 was $2.5 billion at Boston Scientific, down from $2.5 billion in the prior quarter.
  • Across five years, Buildings topped out at $2.5 billion in Q3 2025 and bottomed at $1.3 billion in Q1 2021.
  • The 5-year median for Buildings is $1.8 billion (2023), against an average of $1.8 billion.
  • The largest annual shift saw Buildings increased 4.77% in 2022 before it skyrocketed 32.64% in 2025.
  • A 5-year view of Buildings shows it stood at $1.5 billion in 2021, then increased by 11.29% to $1.7 billion in 2022, then grew by 8.73% to $1.8 billion in 2023, then increased by 9.55% to $2.0 billion in 2024, then rose by 23.03% to $2.5 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Buildings are $2.5 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.2 billion (Q2 2025).